» Articles » PMID: 32335095

A Systematic Review on the Safety of Ramadan Fasting in High-risk Patients with Diabetes

Overview
Specialty Endocrinology
Date 2020 Apr 27
PMID 32335095
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Fasting the holy month of Ramadan is passionately practiced by all Muslim population around the world. Patients with diabetes are generally considered to have a higher risk of fasting. The current international guidelines have risk-stratified the patients with diabetes and other comorbidities to different categories, and the decision of fasting or not is made based on this categorization. Many studies looked at the impact of Ramadan fasting on those high-risk patients, and many are currently being in progress.

Methods: In this systematic review, we conducted an extensive search in PubMed and google scholar engines. Studies filtration focused only on the Randomized controlled trial (RCT) and prospective observational studies accomplished between the year 2007 up to March2019 on impact of Ramadan on patients with diabetes at high risk of fasting.

Results: The global dissemination and implementation of the guidelines for the management of diabetes during Ramadan broke the inertia among health care providers. Additionally, the concept of pre-Ramadan assessment for risk categorization, therapeutic doses modification in hand with self -monitoring blood glucose; have markedly reduced the risk and hospitalisation during Ramadan.

Conclusions: There is still limited data on fasting Ramadan by high risk patients with diabetes. There was minimal diversity in the published results, however, Generally and despite the education, self-titration; the incidences of complications during Ramadan is minimally higher than other times of the year in this group.

Citing Articles

Development and Validation of USM-Insulin Adherence Module for Patients with Type 2 Diabetes Mellitus.

Zainudin A, Rasool A, Mat Nor M, Hassan N, Muhamad R, Mohamed W Malays J Med Sci. 2024; 31(2):98-112.

PMID: 38694587 PMC: 11057828. DOI: 10.21315/mjms2024.31.2.9.


Risk stratification using the 2021 IDF-DAR risk calculator and fasting experience of Bangladeshi subjects with type 2 diabetes in Ramadan: The DAR-BAN study.

Kamrul-Hasan A, Alam M, Kabir M, Chowdhury S, Hannan M, Chowdhury E J Clin Transl Endocrinol. 2023; 31:100315.

PMID: 36861141 PMC: 9969239. DOI: 10.1016/j.jcte.2023.100315.


Management of diabetes during fasting and COVID-19 - Challenges and solutions.

Ahmed W, Arun C, Koshy T, Nair A, Sankar P, Rasheed S J Family Med Prim Care. 2020; 9(8):3797-3806.

PMID: 33110770 PMC: 7586529. DOI: 10.4103/jfmpc.jfmpc_845_20.